[A successful case of hepatocellular carcinoma with portal venous tumor thrombus (Vp2) treated by transcatheter arterial chemoembolization].
We reported a case of hepatocellular carcinoma (HCC) with portal venous tumor thrombus (PVTT) (Vp2) successfully treated by transcatheter arterial chemoembolization (TACE), and the tumor showed complete response and the patient survived for 28 months. A 67-year-old male was diagnosed with HCC in the area of subsegment 5 with PVTT from the P5 to the posterior branch. He was treated by segmental TACE. The tumor markers decreased within normal limits, and localized hepatic infraction in the subsegment 5 and atrophy of the PVTT were recognized. He survived for 28 months with no tumor recurrence after the first TACE. This case suggested that embolization might play a part of treatment to HCC with PVTT, if the liver function was preserved and the lesion of liver infraction was limited.
Noda
Takehiro
T
Dept. of Surgery, Graduate School of Medicine, Osaka University.
Nagano
Hiroaki
H
Miyamoto
Atsushi
A
Wada
Hiroshi
H
Damdinsuren
Bazarragchaa
B
Marubashi
Shigeru
S
Takeda
Yutaka
Y
Umeshita
Koji
K
Dono
Keizo
K
Ohsuga
Keigo
K
Kim
Tonsok
T
Tomoda
Kaname
K
Nakamura
Hironobu
H
Monden
Morito
M
D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000628:therapy*; D008297:Male; D009360:Neoplastic Cells, Circulating / Q000473:pathology*; D011169:Portal Vein / Q000473:pathology*
D014408:Biomarkers, Tumor